Full Episode
Friday, Aug 19
PBS NewsHour
  • Episodes
  • Podcasts
  • Subscribe
  • The Latest
  • Politics
    Politics
    • Brooks and Capehart
    • Politics Monday
    • Supreme Court
  • Arts
    Arts
    • CANVAS
    • Poetry
    • Now Read This
  • Nation
    Nation
    • Supreme Court
    • Race Matters
    • Essays
    • Brief But Spectacular
  • World
    World
    • Agents for Change
  • Economy
    Economy
    • Making Sen$e
    • Paul Solman
  • Science
    Science
    • The Leading Edge
    • ScienceScope
    • Basic Research
    • Innovation and Invention
  • Health
    Health
    • Long-Term Care
  • Education
    Education
    • Teachers' Lounge
    • Student Reporting Labs
  • For Teachers
    Education
    • Newshour Classroom
  • NewsHour Shop
  • About
    • Feedback
    • Funders
    • Support
    • Jobs

Educate your inbox

Subscribe to Here’s the Deal, our politics newsletter for analysis you won’t find anywhere else.

Form error message goes here.

Thank you. Please check your inbox to confirm.

Nation
PBS NewsHour

Get news alerts from PBS NewsHour

Turn on desktop notifications?

gene therapy

  • Full Episodes
  • Podcasts
  • Subscribe
  • Live
File Photo by REUTERS/Jason Reed

Health Aug 19

FDA blocks much-anticipated BioMarin hemophilia gene therapy

By Linda A. Johnson, Associated PRess

Science Mar 04

Gene therapy was a boy’s last chance to stop leukemia. And it worked.

At least 50 children are in remission because of a breakthrough treatment that engineers the body’s own immune system to fight cancer.

By Lesley McClurg, KQED Science

Health Jan 14

Luxturna
At $850,000, price for new childhood blindness gene therapy four times too high, analysis says

Luxturna, a gene therapy with a list price $850,000, is the latest flashpoint in the debate over how to afford innovative medicines.

By Andrew Joseph, STAT

Health Oct 15

We may soon have our first $1 million drug. Who will pay for it? And how?

As the first gene therapies approach the market, drug makers, insurers, and patients are debating complex questions about cost, value, and payment plans.

By Meghana Keshavan, STAT

Health Aug 30

A sign marks a building on Novartis' campus in Cambridge
U.S. clears first ‘gene therapy’ for tough childhood leukemia

Opening a new era in cancer care, the Food and Drug Administration on Wednesday approved the first treatment that genetically engineers patients' own blood cells into an army of assassins to seek and destroy childhood leukemia.

By Lauran Neergaard, Associated Press

May 18

Watch
No image
Mapping the Genomes of Crocodiles and Alligators

Science Nation video mapping genomes of alligators crocodiles and bats…

Continue watching

Dec 08

No image
Questions and Answers with Dr. Kathy Zoon

By PBS NewsHour

Dr. Kathy Zoon of the federal Food and Drug Administration oversees the roughly 200 gene therapy clinical trials now underway in the United States.

Continue reading

Support Provided By: Learn more

Educate your inbox

Subscribe to Here’s the Deal, our politics newsletter for analysis you won’t find anywhere else.

Form error message goes here.

Thank you. Please check your inbox to confirm.

Full Episode
Friday, Aug 19

Additional Support Provided By:

  • BDO
  • BNSF Railway
  • Consumer Cellular
  • Corporation for Public Broadcasting
  • Fidelity
  • Friends of the NewsHour
PBS NewsHour

© 1996 - 2022 NewsHour Productions LLC. All Rights Reserved.

Sections

  • The Latest
  • Politics
  • Arts
  • Nation
  • World
  • Economy
  • Science
  • Health
  • Education

About

  • About Us
  • TV Schedule
  • Press
  • Feedback
  • Funders
  • Support
  • Subscribe
  • NewsHour West
  • Jobs
  • Privacy

Stay Connected

  • Facebook
  • Twitter
  • YouTube
  • RSS

Subscribe to ‘Here's the Deal,’ our politics newsletter

Form error message goes here.

Thank you. Please check your inbox to confirm.

Support our journalism

Learn more about Friends of the NewsHour.

Support for NewsHour Provided By

  • BDO
  • BNSF Railway
  • Consumer Cellular
  • Corporation for Public Broadcasting
  • Fidelity
  • Viewers Like You